Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study

REV1TAL Working Grp

doi:10.1016/S0168-8278(17)31444-7

Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study

REV1TAL Working Grp

UWA Medical School

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

38 Citations (Scopus)

Original language	English
Pages (from-to)	S521-S521
Number of pages	1
Journal	Journal of Hepatology
Volume	66
Issue number	1
DOIs	https://doi.org/10.1016/S0168-8278(17)31444-7
Publication status	Published - 2017
Event	International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver - Amsterdam, Netherlands Duration: 19 Apr 2017 → 23 Apr 2017

Access to Document

10.1016/S0168-8278(17)31444-7

Cite this

@article{62f9c096bb72441eabc6c386ffeee8f6,

title = "Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study",

author = "{REV1TAL Working Grp} and Lubel, {J. S.} and S. Pianko and A. Thompson and S. Strasser and G. Dore and K. Stuart and G. MacQuillan and D. Iser and J. Mitchell and A. Gazzola and S. Chivers and G. Mishra and P. Gow and J. George and J. Gough and E. Tse and A. Zekry and M. Levy and V. Fragomeli and B. Morales and J. Sasadeusz and S. Nazareth and S. Bollipo and T. Jones and A. Wade and W. Cheng and A. Wigg and S. Roberts",

year = "2017",

doi = "10.1016/S0168-8278(17)31444-7",

language = "English",

volume = "66",

pages = "S521--S521",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Pergamon",

number = "1",

note = "International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver ; Conference date: 19-04-2017 Through 23-04-2017",

}

Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study. / REV1TAL Working Grp.

In: Journal of Hepatology, Vol. 66, No. 1, 2017, p. S521-S521.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study

AU - REV1TAL Working Grp

AU - Lubel, J. S.

AU - Pianko, S.

AU - Thompson, A.

AU - Strasser, S.

AU - Dore, G.

AU - Stuart, K.

AU - MacQuillan, G.

AU - Iser, D.

AU - Mitchell, J.

AU - Gazzola, A.

AU - Chivers, S.

AU - Mishra, G.

AU - Gow, P.

AU - George, J.

AU - Gough, J.

AU - Tse, E.

AU - Zekry, A.

AU - Levy, M.

AU - Fragomeli, V.

AU - Morales, B.

AU - Sasadeusz, J.

AU - Nazareth, S.

AU - Bollipo, S.

AU - Jones, T.

AU - Wade, A.

AU - Cheng, W.

AU - Wigg, A.

AU - Roberts, S.

PY - 2017

Y1 - 2017

U2 - 10.1016/S0168-8278(17)31444-7

DO - 10.1016/S0168-8278(17)31444-7

M3 - Abstract/Meeting Abstract

VL - 66

SP - S521-S521

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 1

T2 - International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver

Y2 - 19 April 2017 through 23 April 2017

ER -